AU StockDetailed Quotes

Provided by Tiger Fintech (Singapore) Pte. Ltd.

FIREBRICK PHARMA LTD

0.072

-0.004-5.26%

Volume:57.18K

Turnover:4.12K

Market Cap:16.17M

PE:-8.01

High:0.077

Open:0.077

Low:0.072

Close:0.076

Loading ...

Overview Company News Filings

BRIEF-Firebrick Pharma Secures Strategic Investment From Philippines Partner

Firebrick Pharma Receives AU$1 Million Investment From Philippine Partner; Shares Up 9%

MT Newswires Live

BUZZ-Australia's Firebrick Pharma hits over 10-month high on securing investment

Firebrick Pharma Ltd-Proposed Issue of Securities - Fre

THOMSON REUTERS

Firebrick Pharma Ltd - Firebrick Secures a$1.1M Strategic Investment From Philippines Partner

THOMSON REUTERS

BRIEF-Firebrick Pharma Says Seeks Trading Halt Pending Announcement Regarding A Share Placement

Firebrick Pharma - Seeks Trading Halt Pending Announcement Regarding a Share Placement

THOMSON REUTERS

Invest in the Future of Healthcare – Firebrick Pharma’s Investor Webinar

The Market Herald

Firebrick Pharma First Half 2025 Earnings: AU$0.007 loss per share (vs AU$0.005 loss in 1H 2024)

Simply Wall St.

Firebrick Pharma Signs License, Distribution Agreement to Sell Nasal Spray in Fiji, South Pacific, Shares Down 4%

MT Newswires Live

BRIEF-Firebrick Pharma Executes License And Distribution Agreement For Nasodine Nasal Spray

Firebrick Pharma - License and Distribution Agreement With Makans Limited for Nasodine Nasal Spray

THOMSON REUTERS

The world needs Nasodine: Here’s why…

The Market Herald

Firebrick Pharma Removes Nasal Spray Competitor in Singapore for Patent Violation

MT Newswires Live

Firebrick Pharma Ltd-Consulting Agreement Extended to Grow Asia Sales

THOMSON REUTERS

History tells us there’ll be another pandemic. Given that, has Firebrick Pharma been wildly overlooked?

The Market Herald

Firebrick Pharma launching retail Nasodine sales in Singapore

The Market Herald

Firebrick Pharma Ltd-Nasodine Retail Pharmacy Launch in Singapore

THOMSON REUTERS

Firebrick Pharma Obtains COVID-19 Patent for Nasodine in Mexico

MT Newswires Live

BRIEF-Firebrick Pharma Says Nasodine Covid-19 Patent Allowed In Mexico

{"basename":"","ssrTDKData":{"titleTemplate":"%s - Tiger Brokers","title":"Tiger Brokers | Global Stocks, Options & Futures Trading App","description":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","keywords":"tiger brokers,tiger trade,tiger brokers singapore,broker online,stock trading in singapore,share trading singapore,brokerage firm singapore,trading app,stock broker singapore,stock trading platforms,trading account","social":{"ogDescription":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.be62fbe1.png","ogUrl":"https://www.itiger.com/stock/FRE.AU/news"},"companyName":"Tiger Brokers"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"SGP","license":"TBSG","edition":"fundamental","symbol":"FRE.AU","isAnalysisPage":false},"__swrFallback__":{"@#url:\"https://hq.skytigris.cn/stock_info/detail/global\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"FRE.AU\",,,,,undefined,":{"symbol":"FRE.AU","market":"AU","secType":"STK","nameCN":"FIREBRICK PHARMA LTD","latestPrice":0.072,"timestamp":1747807920000,"preClose":0.076,"halted":0,"volume":57176,"delay":0,"nameEN":"FIREBRICK PHARMA LTD","floatShares":104130397,"shares":224576455,"eps":-0.008993,"marketStatus":"Not Yet Opened","change":-0.004,"latestTime":"05-21 16:12:00 AEST","open":0.077,"high":0.077,"low":0.072,"amount":4118,"amplitude":0.065789,"askPrice":0.077,"askSize":14828,"bidPrice":0.07,"bidSize":122999,"shortable":3,"etf":0,"ttmEps":-0.008993,"tradingStatus":0,"nextMarketStatus":{"tag":"Open","tradingStatus":0,"beginTime":1747872000000},"marketStatusCode":0,"adr":0,"exchange":"ASX","adjPreClose":0.076,"openAndCloseTimeList":[[1747785600000,1747807200000]],"volumeRatio":2.63873,"lotSize":1,"tradeCurrency":"AUD"},"@#url:\"https://hq.skytigris.cn/stock_info/fundamental/all\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"FRE.AU\",,,,,undefined,":{"symbol":"FRE.AU","floatShares":104130397,"roa":"-52.89%","roe":"-111.71%","lyrEps":-0.006568,"volumeRatio":2.63873,"shares":224576455,"dividePrice":0,"high":0.077,"amplitude":0.065789,"preClose":0.076,"low":0.072,"week52Low":0.045,"pbRate":"10.80","psRate":"14.29","week52High":0.1,"institutionHeld":0,"latestPrice":0.072,"committee":0.784832,"eps":-0.008993,"divideRate":0,"volume":57176,"delay":0,"ttmEps":-0.008993,"open":0.077,"prevYearClose":0.062,"prevWeekClose":0.071,"prevMonthClose":0.068,"prevQuarterClose":0.091,"fiveDayClose":0.08,"twentyDayClose":0.076,"sixtyDayClose":0.085},"$inf$@#url:\"https://stock-news.skytigris.cn/v2/news/list\",params:#symbols:\"FRE.AU\",pageSize:20,pageCount:1,lang_content:\"en\",edition:\"fundamental\",,,undefined,":[{"items":[{"id":"2516816699","title":"BRIEF-Firebrick Pharma Secures Strategic Investment From Philippines Partner","url":"https://stock-news.laohu8.com/highlight/detail?id=2516816699","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2516816699?lang=en_us&edition=fundamental","pubTime":"2025-03-04 09:21","pubTimestamp":1741051307,"startTime":"0","endTime":"0","summary":"BRIEF-Firebrick Pharma Secures Strategic Investment From Philippines PartnerMarch 4  - Firebrick Pharma Ltd FRE.AX:SECURES STRATEGIC INVESTMENT FROM PHILIPPINES PARTNERFIREBRICK SECURES A$1.1M STRATEGIC INVESTMENT FROM PHILIPPINES PARTNERFurther company coverage: FRE.AX ","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250304:nFWN3PM0Z0:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK7096","FRE.AU"],"gpt_icon":0},{"id":"2516952176","title":"Firebrick Pharma Receives AU$1 Million Investment From Philippine Partner; Shares Up 9%","url":"https://stock-news.laohu8.com/highlight/detail?id=2516952176","media":"MT Newswires Live","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2516952176?lang=en_us&edition=fundamental","pubTime":"2025-03-04 08:55","pubTimestamp":1741049751,"startTime":"0","endTime":"0","summary":"Firebrick Pharma  secured a AU$1.1 million investment from Pharma Nutria, part of the SV More Group of Companies, which includes its Philippine licensing partner, SV More Pharma, according to a Tuesday filing with the Australian bourse.Pharma Nutria is acquiring 11.6 million shares in the company at AU$0.095 apiece, subject to a voluntary escrow of 12 months, the filing said.Proceeds will be used to cover marketing expenses for Nasodine nasal spray in Singapore, new product development for all markets, and other operational working capital, according to the filing.Firebrick Pharma shares rose nearly 9% in morning trade Tuesday.","market":"sg","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["FRE.AU","BK7096"],"gpt_icon":0},{"id":"2516660750","title":"BUZZ-Australia's Firebrick Pharma hits over 10-month high on securing investment","url":"https://stock-news.laohu8.com/highlight/detail?id=2516660750","media":"Reuters","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2516660750?lang=en_us&edition=fundamental","pubTime":"2025-03-04 07:56","pubTimestamp":1741046179,"startTime":"0","endTime":"0","summary":"BUZZ-Australia's Firebrick Pharma hits over 10-month high on securing investment** Shares of Australia's Firebrick Pharma FRE.AX rise as much as 11.1% to A$0.100, their highest level since April 17, 2024** Stock on track to record its second straight day of gains, if trend holds** Pharmaceutical co gets A$1.1 mln  strategic investment from Pharma Nutria N.A. , an entity associated with Firebrick's licensing partner in the Philippines** Adds PNAI is acquiring 11.6 million shares in Firebrick at an issue price of A$0.095 per share, which represents a 5.6% premium to FRE's last closing** New funds will be used to support marketing costs of Nasodine Nasal Spray in Singapore - FRE** Stock has risen 59.7% this year so far  ","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250303:nL3N3PM1T1:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["FRE.AU","BK7096"],"gpt_icon":0},{"id":"2516445661","title":"Firebrick Pharma Ltd-Proposed Issue of Securities - Fre","url":"https://stock-news.laohu8.com/highlight/detail?id=2516445661","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2516445661?lang=en_us&edition=fundamental","pubTime":"2025-03-04 06:12","pubTimestamp":1741039930,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250303:nTUEBSMCLZ:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BK7096","FRE.AU"],"gpt_icon":0},{"id":"2516661449","title":"Firebrick Pharma Ltd - Firebrick Secures a$1.1M Strategic Investment From Philippines Partner","url":"https://stock-news.laohu8.com/highlight/detail?id=2516661449","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2516661449?lang=en_us&edition=fundamental","pubTime":"2025-03-04 06:12","pubTimestamp":1741039923,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250303:nFWN3PM0Z0:2","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["FRE.AU","BK7096"],"gpt_icon":0},{"id":"2514625359","title":"BRIEF-Firebrick Pharma Says Seeks Trading Halt Pending Announcement Regarding A Share Placement","url":"https://stock-news.laohu8.com/highlight/detail?id=2514625359","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2514625359?lang=en_us&edition=fundamental","pubTime":"2025-02-28 06:31","pubTimestamp":1740695509,"startTime":"0","endTime":"0","summary":"BRIEF-Firebrick Pharma Says Seeks Trading Halt Pending Announcement Regarding A Share PlacementFeb 28 (Reuters) - Firebrick Pharma Ltd FRE.AX:SEEKS TRADING HALT PENDING ANNOUNCEMENT REGARDING A SHARE PLACEMENTFurther company coverage: FRE.AX ((Reuters.Briefs@thomsonreuters.com;))","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250227:nFWN3PI2BV:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK7096","FRE.AU"],"gpt_icon":0},{"id":"2514335988","title":"Firebrick Pharma - Seeks Trading Halt Pending Announcement Regarding a Share Placement","url":"https://stock-news.laohu8.com/highlight/detail?id=2514335988","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2514335988?lang=en_us&edition=fundamental","pubTime":"2025-02-28 06:24","pubTimestamp":1740695050,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250227:nFWN3PI2BV:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["FRE.AU","BK7096"],"gpt_icon":0},{"id":"2514419548","title":"Invest in the Future of Healthcare – Firebrick Pharma’s Investor Webinar","url":"https://stock-news.laohu8.com/highlight/detail?id=2514419548","media":"The Market Herald","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2514419548?lang=en_us&edition=fundamental","pubTime":"2025-02-27 12:46","pubTimestamp":1740631560,"startTime":"0","endTime":"0","summary":"Firebrick Pharma  founder and CEO Peter Molloy addressed investors this week around commercialisation of Nasodine, a nasal spray that kills cold and flu viruses without any potential for resistance.The product developed from PVP-iodine  and is available to Australians online.Firebrick is already establishing other markets in the US, Singapore, Fiji, South Pacific and the Philippines.Dr Molloy – who launched Betadine in Australia – speaks about how the human mindset has changed in relation to viruses since COVID. He says there’s also widespread fear of future pandemics.“We’re on a quest,” he says.“We have a moral, ethical obligation to make Nasodine available worldwide.”Firebrick Pharma is a pharmaceutical developer focused on developing and commercialising novel formulations and uses of povidone-iodine.","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://themarketonline.com.au/invest-in-the-future-of-healthcare-firebrick-pharmas-investor-webinar-2025-02-27/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"markerherald_stock","symbols":["FRE.AU","BK4137","BK7096","HCSG"],"gpt_icon":0},{"id":"2514082289","title":"Firebrick Pharma First Half 2025 Earnings: AU$0.007 loss per share (vs AU$0.005 loss in 1H 2024)","url":"https://stock-news.laohu8.com/highlight/detail?id=2514082289","media":"Simply Wall St.","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2514082289?lang=en_us&edition=fundamental","pubTime":"2025-02-25 05:32","pubTimestamp":1740432724,"startTime":"0","endTime":"0","summary":"Firebrick Pharma ( ASX:FRE ) First Half 2025 Results Key Financial Results Revenue: AU$197.1k (down 89% from 1H 2024...","market":"nz","thumbnail":"https://images.simplywall.st/asset/industry/6121000-choice1-main-header/1585186685410","type":0,"news_type":0,"thumbnails":["https://images.simplywall.st/asset/industry/6121000-choice1-main-header/1585186685410"],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://simplywall.st/stocks/au/pharmaceuticals-biotech/asx-fre/firebrick-pharma-shares/news/firebrick-pharma-first-half-2025-earnings-au0007-loss-per-sh","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"simplywall_highlight","symbols":["BK4523","TTM.AU","FRE.AU","BK4099","BK7104","TTM","BK7096"],"gpt_icon":0},{"id":"2510196397","title":"Firebrick Pharma Signs License, Distribution Agreement to Sell Nasal Spray in Fiji, South Pacific, Shares Down 4%","url":"https://stock-news.laohu8.com/highlight/detail?id=2510196397","media":"MT Newswires Live","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2510196397?lang=en_us&edition=fundamental","pubTime":"2025-02-12 11:23","pubTimestamp":1739330639,"startTime":"0","endTime":"0","summary":"Firebrick Pharma (ASX:FRE) has signed a license and distribution agreement with Fiji Islands company Makans, under which Makans will immediately start to promote and sell the Nasodine nasal spray in F","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["FRE.AU","BK7096"],"gpt_icon":0},{"id":"2510248393","title":"BRIEF-Firebrick Pharma Executes License And Distribution Agreement For Nasodine Nasal Spray","url":"https://stock-news.laohu8.com/highlight/detail?id=2510248393","media":"Reuters","labels":["corporation"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2510248393?lang=en_us&edition=fundamental","pubTime":"2025-02-12 09:31","pubTimestamp":1739323907,"startTime":"0","endTime":"0","summary":"BRIEF-Firebrick Pharma Executes License And Distribution Agreement For Nasodine Nasal SprayFeb 12  - Firebrick Pharma Ltd FRE.AX:FIREBRICK PHARMA -  LICENSE AND DISTRIBUTION AGREEMENT WITH MAKANS LIMITED FOR NASODINE NASAL SPRAYFurther company coverage: FRE.AX ","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250212:nFWN3P21P5:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK7096","FRE.AU"],"gpt_icon":0},{"id":"2510368975","title":"Firebrick Pharma -  License and Distribution Agreement With Makans Limited for Nasodine Nasal Spray","url":"https://stock-news.laohu8.com/highlight/detail?id=2510368975","media":"THOMSON REUTERS","labels":["corporation"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2510368975?lang=en_us&edition=fundamental","pubTime":"2025-02-12 05:54","pubTimestamp":1739310842,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250211:nFWN3P21P5:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BK7096","FRE.AU"],"gpt_icon":0},{"id":"2505234469","title":"The world needs Nasodine: Here’s why…","url":"https://stock-news.laohu8.com/highlight/detail?id=2505234469","media":"The Market Herald","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2505234469?lang=en_us&edition=fundamental","pubTime":"2025-01-21 03:00","pubTimestamp":1737399600,"startTime":"0","endTime":"0","summary":"Firebrick Pharma’s  Nasodine germicidal nasal spray product – which is based on PVP-iodine, just like Betadine – promises to shake up the ecosystem of products treating the common cold.Company Executive Chair Dr Peter Molloy, who originally developed Betadine Sore Throat Gargle in Australia, has previously outlined to HotCopper why Nasodine is superior to other cold treatments.The compound is a germicide and not a decongestant or cough suppressant, meaning that unlike other cold treatment drugs, Nasodine actually targets the cause of the common cold.Nasodine is ultimately a disease prevention and treatment product, standing out from the rest.The last time Molloy spoke to HotCopper, we looked at how the recent COVID-19 debacle had heightened awareness, for better or worse, of global disease spreading broadly .We’d suggested we wouldn’t be far away from the next pandemic risk event – and that’s exactly what we’re looking at now, though it’s important to note the World Health Organisation","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://themarketonline.com.au/the-world-needs-nasodine-heres-why-2025-01-21/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"markerherald_stock","symbols":["BK7096","CDC","FRE.AU"],"gpt_icon":0},{"id":"2503456929","title":"Firebrick Pharma Removes Nasal Spray Competitor in Singapore for Patent Violation","url":"https://stock-news.laohu8.com/highlight/detail?id=2503456929","media":"MT Newswires Live","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2503456929?lang=en_us&edition=fundamental","pubTime":"2025-01-14 09:22","pubTimestamp":1736817748,"startTime":"0","endTime":"0","summary":"Firebrick Pharma (ASX:FRE) removed a competitor product to its Nasodine nasal spray from the Singapore market for a violation of its patent, according to a Tuesday filing with the Australian bourse.Th","market":"sg","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["FRE.AU","BK7096"],"gpt_icon":0},{"id":"2492315250","title":"Firebrick Pharma Ltd-Consulting Agreement Extended to Grow Asia Sales","url":"https://stock-news.laohu8.com/highlight/detail?id=2492315250","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2492315250?lang=en_us&edition=fundamental","pubTime":"2024-12-19 05:30","pubTimestamp":1734557400,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20241218:nTUE6LZ4MZ:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BK7096","FRE.AU"],"gpt_icon":0},{"id":"2490815738","title":"History tells us there’ll be another pandemic. Given that, has Firebrick Pharma been wildly overlooked?","url":"https://stock-news.laohu8.com/highlight/detail?id=2490815738","media":"The Market Herald","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2490815738?lang=en_us&edition=fundamental","pubTime":"2024-12-12 05:51","pubTimestamp":1733953860,"startTime":"0","endTime":"0","summary":"We live in a world that’s only just stopped reeling from the international COVID-19 viral pandemic.The same world where microbes and viruses are becoming ever-resistant to antibiotics and other treatments .And where ‘superbugs’ are no longer sci-fi medical concepts but very real problems inside hospitals everywhere, making staph infections look like a breeze in comparison.As the human population rises and urban centres grow denser and denser while international and domestic travel routes become more and more efficient, the threat of disease  is only going to become more and more relevant to our day-to-day lives.Believe me – this finance journalist is just as keen as you are to avoid thinking about the fact we might ever see lockdowns in our lives again.But, the reality is, the risk is there. Viruses are, after all, more ancient than the human race. And they’ll probably outlive us.And, Firebrick’s Nasodine product is already available in the world’s number one economy: The United States","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://themarketonline.com.au/history-tells-us-therell-be-another-pandemic-given-that-has-firebrick-pharma-been-wildly-overlooked-2024-12-12/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"markerherald_stock","symbols":["FRE.AU","BK7096"],"gpt_icon":0},{"id":"2486743534","title":"Firebrick Pharma launching retail Nasodine sales in Singapore","url":"https://stock-news.laohu8.com/highlight/detail?id=2486743534","media":"The Market Herald","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2486743534?lang=en_us&edition=fundamental","pubTime":"2024-11-25 08:07","pubTimestamp":1732493220,"startTime":"0","endTime":"0","summary":"Firebrick Pharma  has inked a deal with Guardian, a pharmacy chain in Singapore, to launch retail sales of its Nasodine product.The antiseptic nasal spray – think ‘Betadine’ when it comes to the name – has been the company’s flagship offering for a while now, advertises on its website as “the spray that kills germs.”The spray does not necessarily target any one condition but instead lends itself to being a nasal spray analogue for alcoholic hand wash.It’s more about satisfying potential user concerns after spending time on public transport and in office buildings, for example, one could be exposing oneself to other people’s germs – an interesting product to watch.Firebrick expects its Nasodine to be available in all of Guardian’s 121 stores across Singapore –including, the company specifically highlighted, 6 at Changi Airport.“Firebrick management will assist in the training of Guardian retail pharmacists to sell Nasodine to consumers,” the company wrote on Monday.Join the discussion: ","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://themarketonline.com.au/firebrick-pharma-launching-retail-nasodine-sales-in-singapore-2024-11-25/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"markerherald_stock","symbols":["BK7096","FRE.AU"],"gpt_icon":0},{"id":"2486133711","title":"Firebrick Pharma Ltd-Nasodine Retail Pharmacy Launch in Singapore","url":"https://stock-news.laohu8.com/highlight/detail?id=2486133711","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2486133711?lang=en_us&edition=fundamental","pubTime":"2024-11-25 05:22","pubTimestamp":1732483375,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20241124:nTUE58MCFP:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BK7096","FRE.AU"],"gpt_icon":0},{"id":"2480010015","title":"Firebrick Pharma Obtains COVID-19 Patent for Nasodine in Mexico","url":"https://stock-news.laohu8.com/highlight/detail?id=2480010015","media":"MT Newswires Live","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2480010015?lang=en_us&edition=fundamental","pubTime":"2024-11-01 10:46","pubTimestamp":1730429206,"startTime":"0","endTime":"0","summary":"Firebrick Pharma  received notice of allowance of Nasodine's COVID-19 patent in Mexico, according to a Friday filing with the Australian bourse.The patent protects the use of Nasodine nasal spray and any other intranasal povidone-iodine preparations as a method of reducing the viral load of SARS-CoV-2 in the nose, the filing stated.The patent is already granted in the US, Australia, and South Africa, with applications in other countries still pending.Firebrick Pharma's shares were up nearly 2% in recent trade.","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["BNTX","XKO.AU","BK7096","FRE.AU","XAO.AU","XJO.AU"],"gpt_icon":0},{"id":"2480201377","title":"BRIEF-Firebrick Pharma Says Nasodine Covid-19 Patent Allowed In Mexico","url":"https://stock-news.laohu8.com/highlight/detail?id=2480201377","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2480201377?lang=en_us&edition=fundamental","pubTime":"2024-11-01 08:55","pubTimestamp":1730422537,"startTime":"0","endTime":"0","summary":"Nov 1 (Reuters) - Firebrick Pharma Ltd   :   * NASODINE COVID-19 PATENT ALLOWED IN MEXICO Further company coverage:    ((Reuters.Briefs@thomsonreuters.com;))","market":null,"thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.rkd.refinitiv.com/api/News/News.svc/REST/News_1/RetrieveStoryML_1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK7096","FRE.AU"],"gpt_icon":0}],"pageSize":20,"totalPage":2,"pageCount":1,"totalSize":37,"code":"91000000","status":"200"}],"@#url:\"https://hq.skytigris.cn/fundamental/corporate_actions/details/FRE.AU\",params:#limit:5,,,undefined,":[],"@#url:\"https://hq.skytigris.cn/fundamental/dividend/history\",params:#symbol:\"FRE.AU\",market:\"AU\",,,undefined,":[]}}